Format

Send to

Choose Destination
Magy Onkol. 2001;45(1):81-88.

[Management of cancer pain]

[Article in Hungarian]

Author information

1
Department of Radiology and Oncotherapy, Semmelweis University, Budapest, Hungary.

Abstract

The morphin-analogue, Durogesic, has robust analgetic effect without repeated side-effects and is suitable for special applications providing it as the first choice for therapy of cancer pain and as an acceptable alternative for CR morphin. Clinical studies not only provided evidences for the pharmacological effectivity of Durogesic but suggested that the quality of life of cancer patients improved significantly as well.

PMID:
12050733
DOI:
HUON.2001.45.1.0081
Free full text

Supplemental Content

Full text links

Icon for Hungarian Oncological Association
Loading ...
Support Center